These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 31326401)
1. Long-Term Safety and Efficacy of Gene-Pulmonary Macrophage Transplantation Therapy of PAP in Csf2ra Arumugam P; Suzuki T; Shima K; McCarthy C; Sallese A; Wessendarp M; Ma Y; Meyer J; Black D; Chalk C; Carey B; Lachmann N; Moritz T; Trapnell BC Mol Ther; 2019 Sep; 27(9):1597-1611. PubMed ID: 31326401 [TBL] [Abstract][Full Text] [Related]
2. Function and Safety of Lentivirus-Mediated Gene Transfer for CSF2RA-Deficiency. Hetzel M; Suzuki T; Hashtchin AR; Arumugam P; Carey B; Schwabbauer M; Kuhn A; Meyer J; Schambach A; Van Der Loo J; Moritz T; Trapnell BC; Lachmann N Hum Gene Ther Methods; 2017 Dec; 28(6):318-329. PubMed ID: 28854814 [TBL] [Abstract][Full Text] [Related]
3. A murine model of hereditary pulmonary alveolar proteinosis caused by homozygous Shima K; Arumugam P; Sallese A; Horio Y; Ma Y; Trapnell C; Wessendarp M; Chalk C; McCarthy C; Carey BC; Trapnell BC; Suzuki T Am J Physiol Lung Cell Mol Physiol; 2022 Mar; 322(3):L438-L448. PubMed ID: 35043685 [TBL] [Abstract][Full Text] [Related]
4. Gene correction of human induced pluripotent stem cells repairs the cellular phenotype in pulmonary alveolar proteinosis. Lachmann N; Happle C; Ackermann M; Lüttge D; Wetzke M; Merkert S; Hetzel M; Kensah G; Jara-Avaca M; Mucci A; Skuljec J; Dittrich AM; Pfaff N; Brennig S; Schambach A; Steinemann D; Göhring G; Cantz T; Martin U; Schwerk N; Hansen G; Moritz T Am J Respir Crit Care Med; 2014 Jan; 189(2):167-82. PubMed ID: 24279725 [TBL] [Abstract][Full Text] [Related]
5. Elderly-onset hereditary pulmonary alveolar proteinosis and its cytokine profile. Ito M; Nakagome K; Ohta H; Akasaka K; Uchida Y; Hashimoto A; Shiono A; Takada T; Nagata M; Tohyama J; Hagiwara K; Kanazawa M; Nakata K; Tazawa R BMC Pulm Med; 2017 Feb; 17(1):40. PubMed ID: 28212655 [TBL] [Abstract][Full Text] [Related]
6. Use of induced pluripotent stem cells to recapitulate pulmonary alveolar proteinosis pathogenesis. Suzuki T; Mayhew C; Sallese A; Chalk C; Carey BC; Malik P; Wood RE; Trapnell BC Am J Respir Crit Care Med; 2014 Jan; 189(2):183-93. PubMed ID: 24279752 [TBL] [Abstract][Full Text] [Related]
7. A toxicology study of Arumugam P; Carey BC; Wikenheiser-Brokamp KA; Krischer J; Wessendarp M; Shima K; Chalk C; Stock J; Ma Y; Black D; Imbrogno M; Collins M; Kalenda Yombo DJ; Sakthivel H; Suzuki T; Lutzko C; Cancelas JA; Adams M; Hoskins E; Lowe-Daniels D; Reeves L; Kaiser A; Trapnell BC Mol Ther Methods Clin Dev; 2024 Jun; 32(2):101213. PubMed ID: 38596536 [TBL] [Abstract][Full Text] [Related]
8. Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA. Suzuki T; Sakagami T; Rubin BK; Nogee LM; Wood RE; Zimmerman SL; Smolarek T; Dishop MK; Wert SE; Whitsett JA; Grabowski G; Carey BC; Stevens C; van der Loo JC; Trapnell BC J Exp Med; 2008 Nov; 205(12):2703-10. PubMed ID: 18955570 [TBL] [Abstract][Full Text] [Related]
9. The influence of genetics on therapeutic developments in pulmonary alveolar proteinosis. Campo I Curr Opin Pulm Med; 2019 May; 25(3):294-299. PubMed ID: 30865035 [TBL] [Abstract][Full Text] [Related]